The role of prostaglandins in allergic lung inflammation and asthma

References

• Ricciotti E, Fitzgerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011;31(5):986-1000
   PubMed Web of Science ®Google Scholar
• Goldblatt MW. A depressor substance in seminal fluid. J Soc Chem Ind (Lond) 1933;52:1056-7
   Google Scholar
• von Euler US. A depressor substance in the vesicular gland. J Physiol 2014;84:21P
   Google Scholar
• Piper PJ, Vane JR. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 1969;223(5201):29-35
   PubMed Web of Science ®Google Scholar
• Dennis EA, Cao J, Hsu YH, et al. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011;111(10):6130-85
   PubMed Web of Science ®Google Scholar
• Balestrieri B, Hsu VW, Gilbert H, et al. Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J Biol Chem 2006;281(10):6691-8
   PubMed Web of Science ®Google Scholar
• Giannattasio G, Fujioka D, Xing W, et al. Group V secretory phospholipase A2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function. J Immunol 2010;185(7):4430-8
   PubMed Web of Science ®Google Scholar
• Henderson WRJr, Oslund RC, Bollinger JG, et al. Blockade of human group X secreted phospholipase A2 (GX-sPLA2)-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective GX-sPLA2 inhibitor. J Biol Chem 2011;286(32):28049-55
   PubMed Web of Science ®Google Scholar
• Hallstrand TS, Chi EY, Singer AG, et al. Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2007;176(11):1072-8
   PubMed Web of Science ®Google Scholar
• Hallstrand TS, Lai Y, Ni Z, et al. Relationship between levels of secreted phospholipase A(2) groups IIA and X in the airways and asthma severity. Clin Exp Allergy 2011;41(6):801-10
   PubMed Web of Science ®Google Scholar
• Lai Y, Oslund RC, Bollinger JG, et al. Eosinophil cysteinyl leukotriene synthesis mediated by exogenous secreted phospholipase A2 group X. J Biol Chem 2010;285(53):41491-500
   PubMed Web of Science ®Google Scholar
• Sokolowska M, Stefanska J, Wodz-Naskiewicz K, et al. Cytosolic phospholipase A2 group IVA is overexpressed in patients with persistent asthma and regulated by the promoter microsatellites. J Allergy Clin Immunol 2010;125(6):1393-5
   PubMed Web of Science ®Google Scholar
• Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008;358(1):28-35
   PubMed Web of Science ®Google Scholar
• Smith WL, Urade Y, Jakobsson PJ. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev 2011;111(10):5821-65
   PubMed Web of Science ®Google Scholar
• Kang YJ, Mbonye UR, Delong CJ, et al. Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 2007;46(2):108-25
   PubMed Web of Science ®Google Scholar
• Ferguson S, Hebert RL, Laneuville O. NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line. J Am Soc Nephrol 1999;10(11):2261-71
   PubMed Web of Science ®Google Scholar
• Sorli CH, Zhang HJ, Armstrong MB, et al. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci USA 1998;95(4):1788-93
   PubMed Web of Science ®Google Scholar
• Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000;89(12):2637-45
   PubMed Web of Science ®Google Scholar
• Fitzgerald GA. Coxibs and cardiovascular disease. N Engl J Med 2004;351(17):1709-11
   PubMed Web of Science ®Google Scholar
• Sousa A, Pfister R, Christie PE, et al. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997;52(11):940-5
   PubMed Web of Science ®Google Scholar
• Demoly P, Jaffuel D, Lequeux N, et al. Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Respir Crit Care Med 1997;155(2):670-5
   PubMed Web of Science ®Google Scholar
• Redington AE, Meng QH, Springall DR, et al. Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax 2001;56(5):351-7
   PubMed Web of Science ®Google Scholar
• Cho W, Kim Y, Jeoung DI, et al. IL-4 and IL-13 suppress prostaglandins production in human follicular dendritic cells by repressing COX-2 and mPGES-1 expression through JAK1 and STAT6. Mol Immunol 2011;48(6-7):966-72
   PubMed Web of Science ®Google Scholar
• Aksoy MO, Li X, Borenstein M, et al. Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells. J Allergy Clin Immunol 1999;103(6):1081-91
   PubMed Web of Science ®Google Scholar
• Pujols L, Benitez P, Alobid I, et al. Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo. Eur Respir J 2009;33(3):502-8
   PubMed Web of Science ®Google Scholar
• Ebbens FA, Maldonado M, de Groot EJ, et al. Topical glucocorticoids downregulate COX-1 positive cells in nasal polyps. Allergy 2009;64(1):96-103
   PubMed Web of Science ®Google Scholar
• Iniguez MA, Punzon C, Fresno M. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J Immunol 1999;163(1):111-19
   PubMed Web of Science ®Google Scholar
• Kang YJ, Mbonye UR, Delong CJ, et al. Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 2007;46(2):108-25
   PubMed Web of Science ®Google Scholar
• Liu MC, Bleecker ER, Lichtenstein LM, et al. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990;142(1):126-32
   PubMed Web of Science ®Google Scholar
• Liu MC, Hubbard WC, Proud D, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis 1991;144(1):51-8
   PubMed Web of Science ®Google Scholar
• Liu MC, Proud D, Lichtenstein LM, et al. Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol 2001;108(1):29-38
   PubMed Web of Science ®Google Scholar
• Fish JE, Ankin MG, Adkinson NFJr, et al. Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects: evidence for altered arachidonic acid metabolism in asthma. Am Rev Respir Dis 1981;123(6):609-14
   PubMed Web of Science ®Google Scholar
• Kirby JG, Hargreave FE, Cockcroft DW, et al. Effect of indomethacin on allergen-induced asthmatic responses. J Appl Physiol 1989;66(2):578-83
   PubMed Web of Science ®Google Scholar
• Sladek K, Dworski R, Fitzgerald GA, et al. Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. Am Rev Respir Dis 1990;141(6):1441-5
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, Jones GL. The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. Am Rev Respir Dis 1986;134(1):69-72
   PubMed Web of Science ®Google Scholar
• Carey MA, Germolec DR, Bradbury JA, et al. Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice. Am J Respir Crit Care Med 2003;167(11):1509-15
   PubMed Web of Science ®Google Scholar
• Zeldin DC, Wohlford-Lenane C, Chulada P, et al. Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2001;25(4):457-65
   PubMed Web of Science ®Google Scholar
• Card JW, Carey MA, Bradbury JA, et al. Cyclooxygenase-1 overexpression decreases Basal airway responsiveness but not allergic inflammation. J Immunol 2006;177(7):4785-93
   PubMed Web of Science ®Google Scholar
• Nakata J, Kondo M, Tamaoki J, et al. Augmentation of allergic inflammation in the airways of cyclooxygenase-2-deficient mice. Respirology 2005;10(2):149-56
   PubMed Web of Science ®Google Scholar
• Peebles RSJr, Dworski R, Collins RD, et al. Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. Am J Respir Crit Care Med 2000;162:676-81
   PubMed Web of Science ®Google Scholar
• Peebles RSJr, Hashimoto K, Sheller JR, et al. Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent. J Immunol 2005;175(12):8253-9
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Sheller JR, Morrow JD, et al. Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms. J Immunol 2005;174(1):525-32
   PubMed Web of Science ®Google Scholar
• Peebles RSJr, Hashimoto K, Morrow JD, et al. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am J Respir Crit Care Med 2002;165(8):1154-60
   PubMed Web of Science ®Google Scholar
• Laouini D, Elkhal A, Yalcindag A, et al. COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization. J Allergy Clin Immunol 2005;116(2):390-6
   PubMed Web of Science ®Google Scholar
• Oguma T, Asano K, Shiomi T, et al. Cyclooxygenase-2 expression during allergic inflammation in guinea-pig lungs. Am J Respir Crit Care Med 2002;165(3):382-6
   PubMed Web of Science ®Google Scholar
• Selg E, Lastbom L, Ryrfeldt A, et al. Effects of selective and non-selective COX inhibitors on antigen-induced release of prostanoid mediators and bronchoconstriction in the isolated perfused and ventilated guinea pig lung. Prostaglandins Leukot Essent Fatty Acids 2008;78(2):89-97
   PubMed Web of Science ®Google Scholar
• Safholm J, Dahlen SE, Delin I, et al. PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors. Br J Pharmacol 2013;168(4):794-806
   PubMed Web of Science ®Google Scholar
• Martin TR, Gerard NP, Galli SJ, et al. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol 1988;64(6):2318-23
   PubMed Web of Science ®Google Scholar
• Luna-Gomes T, Magalhaes KG, Mesquita-Santos FP, et al. Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation. J Immunol 2011;187(12):6518-26
   PubMed Web of Science ®Google Scholar
• Hirai H, Tanaka K, Yoshie O, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193(2):255-62
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Shichijo M, Okano M, et al. CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses. Eur J Pharmacol 2005;524(1-3):30-7
   PubMed Web of Science ®Google Scholar
• Mutalithas K, Guillen C, Day C, et al. CRTH2 expression on T cells in asthma. Clin Exp Immunol 2010;161(1):34-40
   PubMed Web of Science ®Google Scholar
• Johnston SL, Freezer NJ, Ritter W, et al. Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor. Eur Respir J 1995;8(3):411-15
   PubMed Web of Science ®Google Scholar
• Larsson AK, Hagfjard A, Dahlen SE, et al. Prostaglandin D(2) induces contractions through activation of TP receptors in peripheral lung tissue from the guinea pig. Eur J Pharmacol 2011;669(1-3):136-42
   PubMed Web of Science ®Google Scholar
• Murray M, Webb MS, O’Callaghan C, et al. Respiratory status and allergy after bronchiolitis. Arch Dis Child 1992;67(4):482-7
   PubMed Web of Science ®Google Scholar
• Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128(4):597-602
   PubMed Web of Science ®Google Scholar
• Proud D, Sweet J, Stein P, et al. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 1990;85(5):896-905
   PubMed Web of Science ®Google Scholar
• Charlesworth EN, Kagey-Sobotka A, Schleimer RP, et al. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 1991;146(2):671-6
   PubMed Web of Science ®Google Scholar
• Daham K, Song WL, Lawson JA, et al. Effects of celecoxib on major prostaglandins in asthma. Clin Exp Allergy 2011;41(1):36-45
   PubMed Web of Science ®Google Scholar
• Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990;86(6 Pt 1):924-35
   PubMed Web of Science ®Google Scholar
• Flower RJ, Harvey EA, Kingston WP. Inflammatory effects of prostaglandin D2 in rat and human skin. Br J Pharmacol 1976;56(2):229-33
   PubMed Web of Science ®Google Scholar
• Woodward DF, Hawley SB, Williams LS, et al. Studies on the ocular pharmacology of prostaglandin D2. Invest Ophthalmol Vis Sci 1990;31(1):138-46
   PubMed Web of Science ®Google Scholar
• Emery DL, Djokic TD, Graf PD, et al. Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. J Appl Physiol 1989;67(3):959-62
   PubMed Web of Science ®Google Scholar
• Monneret G, Gravel S, Diamond M, et al. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001;98(6):1942-8
   PubMed Web of Science ®Google Scholar
• Beasley RC, Featherstone RL, Church MK, et al. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. J Appl Physiol 1989;66(4):1685-93
   PubMed Web of Science ®Google Scholar
• Barnes N, Pavord I, Chuchalin A, et al. A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Clin Exp Allergy 2012;42(1):38-48
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Hirata M, Tanaka H, et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000;287(5460):2013-17
   PubMed Web of Science ®Google Scholar
• Fujitani Y, Kanaoka Y, Aritake K, et al. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 2002;168(1):443-9
   PubMed Web of Science ®Google Scholar
• Honda K, Arima M, Cheng G, et al. Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J Exp Med 2003;198(4):533-43
   PubMed Web of Science ®Google Scholar
• Hammad H, de Heer HJ, Soullie T, et al. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J Immunol 2003;171(8):3936-40
   PubMed Web of Science ®Google Scholar
• Hammad H, Kool M, Soullie T, et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 2007;204(2):357-67
   PubMed Web of Science ®Google Scholar
• Bain G, Lorrain DS, Stebbins KJ, et al. Pharmacology of AM211, a potent and selective prostaglandin D2 receptor type 2 antagonist that is active in animal models of allergic inflammation. J Pharmacol Exp Ther 2011;338(1):290-301
   PubMed Web of Science ®Google Scholar
• Gervais FG, Sawyer N, Stocco R, et al. Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonist. Mol Pharmacol 2011;79(1):69-76
   PubMed Web of Science ®Google Scholar
• Crosignani S, Pretre A, Jorand-Lebrun C, et al. Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases. J Med Chem 2011;54(20):7299-317
   PubMed Web of Science ®Google Scholar
• Ueno N, Taketomi Y, Yamamoto K, et al. Analysis of two major intracellular phospholipases A(2) (PLA(2)) in mast cells reveals crucial contribution of cytosolic PLA(2)alpha, not Ca(2+)-independent PLA(2)beta, to lipid mobilization in proximal mast cells and distal fibroblasts. J Biol Chem 2011;286(43):37249-63
   PubMed Web of Science ®Google Scholar
• Tanioka T, Nakatani Y, Semmyo N, et al. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000;275(42):32775-82
   PubMed Web of Science ®Google Scholar
• Kahnt AS, Rorsch F, Diehl O, et al. Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity. Biochem Pharmacol 2013;86(2):286-96
   PubMed Web of Science ®Google Scholar
• Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 2006;119(3):229-40
   PubMed Web of Science ®Google Scholar
• Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol 2012;188(1):21-8
   PubMed Web of Science ®Google Scholar
• Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46(2):205-29
   PubMed Web of Science ®Google Scholar
• Breyer RM, Bagdassarian CK, Myers SA, et al. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001;41:661-90
   PubMed Web of Science ®Google Scholar
• An S, Yang J, Xia M, et al. Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2. Biochem Biophys Res Commun 1993;197(1):263-70
   PubMed Web of Science ®Google Scholar
• Adam M, Boie Y, Rushmore TH, et al. Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Lett 1994;338(2):170-4
   PubMed Web of Science ®Google Scholar
• Churchill L, Chilton FH, Resau JH, et al. Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am Rev Respir Dis 1989;140(2):449-59
   PubMed Web of Science ®Google Scholar
• Delamere F, Holland E, Patel S, et al. Production of PGE2 by bovine cultured airway smooth muscle cells and its inhibition by cyclo-oxygenase inhibitors. Br J Pharmacol 1994;111(4):983-8
   PubMed Web of Science ®Google Scholar
• Pavord ID, Tattersfield AE. Bronchoprotective role for endogenous prostaglandin E2. Lancet 1995;345(8947):436-8
   PubMed Web of Science ®Google Scholar
• Barnett K, Jacoby DB, Nadel JA, et al. The effects of epithelial cell supernatant on contractions of isolated canine tracheal smooth muscle. Am Rev Respir Dis 1988;138(4):780-3
   PubMed Web of Science ®Google Scholar
• Schmidt LM, Belvisi MG, Bode KA, et al. Bronchial epithelial cell-derived prostaglandin E2 dampens the reactivity of dendritic cells. J Immunol 2011;186(4):2095-105
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Moodley YP, Thompson PJ, et al. Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation. Clin Exp Allergy 2010;40(1):85-93
   PubMed Web of Science ®Google Scholar
• Pavord ID, Ward R, Woltmann G, et al. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999;160(6):1905-9
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Watson RM, O’Byrne PM. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1999;159(1):31-6
   PubMed Web of Science ®Google Scholar
• Pavord ID, Wong CS, Williams J, et al. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis 1993;148(1):87-90
   PubMed Web of Science ®Google Scholar
• Melillo E, Woolley KL, Manning PJ, et al. Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1994;149(5):1138-41
   PubMed Web of Science ®Google Scholar
• Sestini P, Armetti L, Gambaro G, et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996;153(2):572-5
   PubMed Web of Science ®Google Scholar
• Hartert TV, Dworski RT, Mellen BG, et al. Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthma. Am J Respir Crit Care Med 2000;162(2 Pt 1):637-40
   PubMed Web of Science ®Google Scholar
• Buckley J, Birrell MA, Maher SA, et al. EP4 receptor as a new target for bronchodilator therapy. Thorax 2011;66(12):1029-35
   PubMed Web of Science ®Google Scholar
• Maher SA, Birrell MA, Belvisi MG. Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. Am J Respir Crit Care Med 2009;180(10):923-8
   PubMed Web of Science ®Google Scholar
• Goncharova EA, Goncharov DA, Zhao H, et al. beta2-adrenergic receptor agonists modulate human airway smooth muscle cell migration via vasodilator-stimulated phosphoprotein. Am J Respir Cell Mol Biol 2012;46(1):48-54
   PubMed Web of Science ®Google Scholar
• Yan H, Deshpande DA, Misior AM, et al. Anti-mitogenic effects of beta-agonists and PGE2 on airway smooth muscle are PKA dependent. FASEB J 2011;25(1):389-97
   PubMed Web of Science ®Google Scholar
• Wasiak W, Szmidt M. A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma. Thorax 1999;54(10):900-4
   PubMed Web of Science ®Google Scholar
• Harmanci E, Ozakyol A, Ozdemir N, et al. Misoprostol has no favorable effect on bronchial hyperresponsiveness in mild asthmatics. Allerg Immunol (Paris) 1998;30(9):298-300
   PubMedGoogle Scholar
• Pawlotsky JM, Ruszniewski P, Reyl-Desmars F, et al. Effects of PGE2, misoprostol, and enprostil on guinea pig enterocyte adenylate cyclase. Clinical implications. Dig Dis Sci 1993;38(2):316-20
   PubMed Web of Science ®Google Scholar
• Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991;146(1):108-13
   PubMed Web of Science ®Google Scholar
• Snijdewint FG, Kalinski P, Wierenga EA, et al. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993;150(12):5321-9
   PubMed Web of Science ®Google Scholar
• Katamura K, Shintaku N, Yamauchi Y, et al. Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J Immunol 1995;155(10):4604-12
   PubMed Web of Science ®Google Scholar
• Hilkens CM, Vermeulen H, van Neerven RJ, et al. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol 1995;25(1):59-63
   PubMed Web of Science ®Google Scholar
• Vieira PL, de Jong EC, Wierenga EA, et al. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 2000;164(9):4507-12
   PubMed Web of Science ®Google Scholar
• Chizzolini C, Chicheportiche R, Alvarez M, et al. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 2008;112(9):3696-703
   PubMed Web of Science ®Google Scholar
• Peacock CD, Misso NL, Watkins DN, et al. PGE 2 and dibutyryl cyclic adenosine monophosphate prolong eosinophil survival in vitro. J Allergy Clin Immunol 1999;104(1):153-62
   PubMed Web of Science ®Google Scholar
• Kita H, Abu-Ghazaleh RI, Gleich GJ, et al. Regulation of Ig-induced eosinophil degranulation by adenosine 3’,5’-cyclic monophosphate. J Immunol 1991;146(8):2712-18
   PubMed Web of Science ®Google Scholar
• Teixeira MM, al Rashed S, Rossi AG, et al. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils. Br J Pharmacol 1997;121(1):77-82
   PubMed Web of Science ®Google Scholar
• Sturm EM, Schratl P, Schuligoi R, et al. Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors. J Immunol 2008;181(10):7273-83
   PubMed Web of Science ®Google Scholar
• Lazzeri N, Belvisi MG, Patel HJ, et al. Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy. Am J Respir Cell Mol Biol 2001;24(1):44-8
   PubMed Web of Science ®Google Scholar
• Gomi K, Zhu FG, Marshall JS. Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism. J Immunol 2000;165(11):6545-52
   PubMed Web of Science ®Google Scholar
• Hogaboam CM, Bissonnette EY, Chin BC, et al. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 1993;104(1):122-9
   PubMed Web of Science ®Google Scholar
• Kaliner M, Austen KF. Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. J Immunol 1974;112(2):664-74
   PubMed Web of Science ®Google Scholar
• Peachell PT, MacGlashan DWJr, Lichtenstein LM, et al. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988;140(2):571-9
   PubMed Web of Science ®Google Scholar
• Leal-Berumen I, O’Byrne P, Gupta A, et al. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. J Immunol 1995;154(9):4759-67
   PubMed Web of Science ®Google Scholar
• Nishigaki N, Negishi M, Honda A, et al. Identification of prostaglandin E receptor ’EP2’ cloned from mastocytoma cells EP4 subtype. FEBS Lett 1995;364(3):339-41
   PubMed Web of Science ®Google Scholar
• Feng C, Beller EM, Bagga S, et al. Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. Blood 2006;107(8):3243-50
   PubMed Web of Science ®Google Scholar
• Mastalerz L, Sanak M, Gawlewicz-Mroczka A, et al. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax 2008;63(1):27-34
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Mastalerz L, Nizankowska E, et al. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med 1996;153(2):567-71
   PubMed Web of Science ®Google Scholar
• Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 2003;111(5):1116-21
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Pawliczak R, Wozniak J, et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000;161(2 Pt 1):391-8
   PubMed Web of Science ®Google Scholar
• Perez-Novo CA, Watelet JB, Claeys C, et al. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005;115(6):1189-96
   PubMed Web of Science ®Google Scholar
• Pierzchalska M, Szabo Z, Sanak M, et al. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. J Allergy Clin Immunol 2003;111(5):1041-8
   PubMed Web of Science ®Google Scholar
• Roca-Ferrer J, Garcia-Garcia FJ, Pereda J, et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. J Allergy Clin Immunol 2011;128(1):66-72
   PubMed Web of Science ®Google Scholar
• Adamusiak AM, Stasikowska-Kanicka O, Lewandowska-Polak A, et al. Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics. Int Arch Allergy Immunol 2012;157(4):354-62
   PubMed Web of Science ®Google Scholar
• Corrigan CJ, Napoli RL, Meng Q, et al. Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma. J Allergy Clin Immunol 2012;129(6):1636-46
   PubMed Web of Science ®Google Scholar
• Ying S, Meng Q, Scadding G, et al. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol 2006;117(2):312-18
   PubMed Web of Science ®Google Scholar
• Jinnai N, Sakagami T, Sekigawa T, et al. Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet 2004;13(24):3203-17
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim YK, Park HW, et al. Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet Genomics 2007;17(4):295-304
   PubMed Web of Science ®Google Scholar
• Kunikata T, Yamane H, Segi E, et al. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol 2005;6(5):524-31
   PubMed Web of Science ®Google Scholar
• Herrerias A, Torres R, Serra M, et al. Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice. Int Arch Allergy Immunol 2009;149(4):323-32
   PubMed Web of Science ®Google Scholar
• Kuehn HS, Jung MY, Beaven MA, et al. Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release. J Biol Chem 2011;286(1):391-402
   PubMed Web of Science ®Google Scholar
• Weller CL, Collington SJ, Hartnell A, et al. Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3. Proc Natl Acad Sci USA 2007;104(28):11712-17
   PubMed Web of Science ®Google Scholar
• Stumm CL, Wettlaufer SH, Jancar S, et al. Airway remodeling in murine asthma correlates with a defect in PGE2 synthesis by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2011;301(5):L636-44
   PubMed Web of Science ®Google Scholar
• Lundequist A, Nallamshetty SN, Xing W, et al. Prostaglandin E(2) exerts homeostatic regulation of pulmonary vascular remodeling in allergic airway inflammation. J Immunol 2010;184(1):433-41
   PubMed Web of Science ®Google Scholar
• Hartney JM, Coggins KG, Tilley SL, et al. Prostaglandin E2 protects lower airways against bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 2006;290(1):L105-13
   PubMed Web of Science ®Google Scholar
• Sheller JR, Mitchell D, Meyrick B, et al. EP(2) receptor mediates bronchodilation by PGE(2) in mice. J Appl Physiol 2000;88(6):2214-18
   PubMed Web of Science ®Google Scholar
• Tilley SL, Hartney JM, Erikson CJ, et al. Receptors and pathways mediating the effects of prostaglandin E2 on airway tone. Am J Physiol Lung Cell Mol Physiol 2003;284(4):L599-606
   PubMed Web of Science ®Google Scholar
• Liu T, Laidlaw TM, Katz HR, et al. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci USA 2013;110(42):16987-92
   PubMed Web of Science ®Google Scholar
• Komoto J, Yamada T, Watanabe K, et al. Prostaglandin F2alpha formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost. Biochemistry 2006;45(7):1987-96
   PubMed Web of Science ®Google Scholar
• Suzuki-Yamamoto T, Nishizawa M, Fukui M, et al. cDNA cloning, expression and characterization of human prostaglandin F synthase. FEBS Lett 1999;462(3):335-40
   PubMed Web of Science ®Google Scholar
• Hata AN, Breyer RM. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 2004;103(2):147-66
   PubMed Web of Science ®Google Scholar
• Breyer MD, Breyer RM. G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol 2001;63:579-605
   PubMed Web of Science ®Google Scholar
• Mathe AA, Hedqvist P, Holmgren A, et al. Bronchial hyperreactivity to prostaglandin F 2 and histamine in patients with asthma. Br Med J 1973;1(5847):193-6
   PubMed Web of Science ®Google Scholar
• Smith AP, Cuthbert MF. Prostaglandins and resistance to beta adrenoceptor stimulants. Br Med J 1972;2(806):166
   PubMedGoogle Scholar
• Smith AP, Cuthbert MF, Dunlop LS. Effects of inhaled prostaglandins E1, E2, and F2alpha on the airway resistance of healthy and asthmatic man. Clin Sci Mol Med 1975;48(5):421-30
   PubMedGoogle Scholar
• Kharitonov SA, Sapienza MA, Barnes PJ, et al. Prostaglandins E2 and F2alpha reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes. Am J Respir Crit Care Med 1998;158(5 Pt 1):1374-8
   PubMed Web of Science ®Google Scholar
• Oga T, Matsuoka T, Yao C, et al. Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta. Nat Med 2009;15(12):1426-30
   PubMed Web of Science ®Google Scholar
• Nakayama T. Prostacyclin analogues: prevention of cardiovascular diseases. Cardiovasc Hematol Agents Med Chem 2006;4(4):351-9
   PubMedGoogle Scholar
• Breyer RM, Kennedy CR, Zhang Y, et al. Structure-function analyses of eicosanoid receptors. Physiologic and therapeutic implications. Ann N Y Acad Sci 2000;905:221-31
   PubMed Web of Science ®Google Scholar
• Zhou W, Hashimoto K, Goleniewska K, et al. Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J Immunol 2007;178(2):702-10
   PubMed Web of Science ®Google Scholar
• Muller T, Durk T, Blumenthal B, et al. Iloprost has potent anti-inflammatory properties on human monocyte-derived dendritic cells. Clin Exp Allergy 2010;40(8):1214-21
   PubMed Web of Science ®Google Scholar
• Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79(4):1193-226
   PubMed Web of Science ®Google Scholar
• Komhoff M, Lesener B, Nakao K, et al. Localization of the prostacyclin receptor in human kidney. Kidney Int 1998;54(6):1899-908
   PubMed Web of Science ®Google Scholar
• Zhou W, Blackwell TS, Goleniewska K, et al. Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells. J Leukoc Biol 2007;81(3):809-17
   PubMed Web of Science ®Google Scholar
• Schulman ES, Newball HH, Demers LM, et al. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis 1981;124(4):402-6
   PubMed Web of Science ®Google Scholar
• Schulman ES, Adkinson NFJr, Newball HH. Cyclooxygenase metabolites in human lung anaphylaxis: airway vs. parenchyma. J Appl Physiol Respir Environ Exerc Physiol 1982;53(3):589-95
   PubMed Web of Science ®Google Scholar
• Shephard EG, Malan L, Macfarlane CM, et al. Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment. Br J Clin Pharmacol 1985;19(4):459-70
   PubMed Web of Science ®Google Scholar
• Bianco S, Robuschi M, Grugni A, et al. Effect of prostacyclin on antigen induced immediate bronchoconstriction in asthmatic patients. Prostaglandins Med 1979;3(1):39-45
   PubMedGoogle Scholar
• Bianco S, Robuschi M, Ceserani R, et al. Effects of prostacyclin on aspecifically and specifically induced bronchoconstriction in asthmatic patients. Eur J Respir Dis Suppl 1980;106:81-7
   PubMedGoogle Scholar
• Hardy C, Robinson C, Lewis RA, et al. Airway and cardiovascular responses to inhaled prostacyclin in normal and asthmatic subjects. Am Rev Respir Dis 1985;131(1):18-21
   PubMed Web of Science ®Google Scholar
• Nizankowska E, Czerniawska-Mysik G, Szczeklik A. Lack of effect of i.v. prostacyclin on aspirin-induced asthma. Eur J Respir Dis 1986;69(5):363-8
   PubMedGoogle Scholar
• Hardy CC, Bradding P, Robinson C, et al. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol 1988;64(4):1567-74
   PubMed Web of Science ®Google Scholar
• Fujimura M, Ozawa S, Matsuda T. Effect of oral administration of a prostacyclin analog (OP-41483) on pulmonary function and bronchial responsiveness in stable asthmatic subjects. J Asthma 1991;28(6):419-24
   PubMed Web of Science ®Google Scholar
• Majeski E, Hoskins A, Dworski R, et al. Iloprost inhalation in mild asthma. J Asthma 2012;49(9):961-5
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Tokuoka S, Masuda T, et al. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br J Pharmacol 2002;137(3):315-22
   PubMed Web of Science ®Google Scholar
• Nagao K, Tanaka H, Komai M, et al. Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am J Respir Cell Mol Biol 2003;29(3 Pt 1):314-20
   PubMed Web of Science ®Google Scholar
• Lovgren AK, Jania LA, Hartney JM, et al. COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2006;291(2):L144-56
   PubMed Web of Science ®Google Scholar
• Zhou W, Dowell DR, Geraci MW, et al. PGI synthase overexpression protects against bleomycin-induced mortality and is associated with increased Nqo 1 expression. Am J Physiol Lung Cell Mol Physiol 2011;301(4):L615-22
   PubMed Web of Science ®Google Scholar
• Idzko M, Hammad H, van Nimwegen M, et al. Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest 2007;117(2):464-72
   PubMed Web of Science ®Google Scholar
• Toki S, Goleniewska K, Huckabee MM, et al. PGI2 signaling inhibits antigen uptake and increases migration of immature dendritic cells. J Leukoc Biol 2013;94(1):77-88
   PubMed Web of Science ®Google Scholar
• Boswell MG, Zhou W, Newcomb DC, et al. PGI2 as a regulator of CD4+ subset differentiation and function. Prostaglandins Other Lipid Mediat 2011;96(1-4):21-6
   PubMed Web of Science ®Google Scholar
• Dorris SL, Peebles RSJr. PGI(2) as a regulator of inflammatory diseases. Mediators Inflamm 2012;2012:926968
   PubMed Web of Science ®Google Scholar
• Whittle BJ, Moncada S. Pharmacological interactions between prostacyclin and thromboxanes. Br Med Bull 1983;39(3):232-8
   PubMed Web of Science ®Google Scholar
• Miyata A, Yokoyama C, Ihara H, et al. Characterization of the human gene (TBXAS1) encoding thromboxane synthase. Eur J Biochem 1994;224(2):273-9
   PubMedGoogle Scholar
• Ruan KH. Advance in understanding the biosynthesis of prostacyclin and thromboxane A2 in the endoplasmic reticulum membrane via the cyclooxygenase pathway. Mini Rev Med Chem 2004;4(6):639-47
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Sweetman BJ, Oates JA. Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem 1981;256(16):8384-93
   PubMed Web of Science ®Google Scholar
• Raychowdhury MK, Yukawa M, Collins LJ, et al. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem 1994;269(30):19256-61
   PubMed Web of Science ®Google Scholar
• Huang JS, Ramamurthy SK, Lin X, et al. Cell signalling through thromboxane A2 receptors. Cell Signal 2004;16(5):521-33
   PubMed Web of Science ®Google Scholar
• Hirata T, Ushikubi F, Kakizuka A, et al. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 1996;97(4):949-56
   PubMed Web of Science ®Google Scholar
• Grosser T, Fries S, Fitzgerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006;116(1):4-15
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Sweetman BJ, Lewis RA, et al. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 1980;303(24):1400-4
   PubMed Web of Science ®Google Scholar
• Taylor IK, Ward PS, O’Shaughnessy KM, et al. Thromboxane A2 biosynthesis in acute asthma and after antigen challenge. Am Rev Respir Dis 1991;143(1):119-25
   PubMed Web of Science ®Google Scholar
• Lupinetti MD, Sheller JR, Catella F, et al. Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. Am Rev Respir Dis 1989;140(4):932-5
   PubMed Web of Science ®Google Scholar
• Seltzer J, Bigby BG, Stulbarg M, et al. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 1986;60(4):1321-6
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, Leikauf GD, Aizawa H, et al. Leukotriene B4 induces airway hyperresponsiveness in dogs. J Appl Physiol 1985;59(6):1941-6
   PubMed Web of Science ®Google Scholar
• Aizawa H, Inoue H, Nakano H, et al. Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics. Prostaglandins Leukot Essent Fatty Acids 1998;59(3):185-90
   PubMed Web of Science ®Google Scholar
• Hoshino M, Sim J, Shimizu K, et al. Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma. J Allergy Clin Immunol 1999;103(6):1054-61
   PubMed Web of Science ®Google Scholar
• Shi H, Yokoyama A, Kohno N, et al. Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice. Eur Respir J 1998;11(3):624-9
   PubMed Web of Science ®Google Scholar
• Liu T, Laidlaw TM, Feng C, et al. Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation. Proc Natl Acad Sci USA 2012;109(31):12692-7
   PubMed Web of Science ®Google Scholar